Short- and long-term safety of glaucoma drugs

Pharmacology, Toxicology and Pharmaceutical Science

• Glaucoma 100%
• Disease 33%
• Cholinergic Receptor Stimulating Agent 33%
• Adverse Event 33%
• Adrenergic Receptor Stimulating Agent 33%
• Adrenergic Receptor Blocking Agent 33%
• Carbonate Dehydratase Inhibitor 33%

Keyphrases

• Adrenergic Blockers 33%
• Chronic Neurodegeneration 33%